Big buzz over Mounjaro launch but here’s why India’s anti-obesity drug market may only take off next yr

The company has introduced the drug in two strengths—2.5 mg vials priced at Rs 3,500 and…

Mounjaro hits shelves in India: How Eli Lilly’s anti-diabetes drug compares with Ozempic — price, side effects and more | Mint

Eli Lilly has introduced Mounjaro (tirzepatide), a weekly injectable medication for obesity and type 2 diabetes,…

Is obesity a disease? | Mint

For years there has been a push to recognise obesity as a disease in its own…

23andMe Exits Drug Development to Step Into Weight-Loss Wave

(Bloomberg) — 23andMe Holding Co.’s strategy is shifting as the struggling DNA-testing firm shuts down its…

Weight-loss Medicine Semaglutide Also Helps Against Heart-related Diseases: Study – News18

As per the reports, at least 17,000 people were part of the experiment. Semaglutide is not…

How the new generation of weight-loss drugs work

This article is part of our Summer reads series. Visit the full collection for book lists,…